Treatment

Implementing Adolescent SBIRT

Soberay, A., DeSorrento, L., Pietruszewski, P., Sitz, M., & Levy, S. (2021). Implementing adolescent SBIRT: Findings from the FaCES project. Substance abuse, 42(4), 751-759.

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based approach to early intervention of substance use.

This mixed-methods evaluation assessed the implementation of an adolescent SBIRT change package across 13 primary care clinics in the United States. These clinics participated in an 18-month learning collaborative, during which they received training and technical assistance on SBIRT practices. 

Severe bacterial infections in people who inject drugs: The role of injection-related tissue damage

Hrycko, A., Mateu-Gelabert, P., Ciervo, C. et al. Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage. Harm Reduct J 19, 41 (2022). https://doi.org/10.1186/s12954-022-00624-6
Publication Date

Abstract

Background

In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral infections. Severe bacterial infections (SBI) associated with intravenous drug use have been increasing in frequency in the U.S. over the last decade.

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial. Drug and Alcohol Dependence Reports, 3, 100045.

Abstract

Background

Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and acceptability of MySafeRx, a mobile platform integrating motivational coaching, adherence monitoring, and electronic dispensing during office-based B/N treatment.

White House Releases 2022 National Drug Control Strategy that Outlines Comprehensive Path Forward to Address Addiction and the Overdose Epidemic

Today, President Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have taken a heartbreaking toll, claiming 106,854 lives in the most recent 12-month period. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic. The Strategy focuses on two critical drivers of the epidemic: untreated addiction and drug trafficking. It instructs federal agencies to

UNODC Training for Albanian Policymakers on the Nature, Prevention, Treatment and Care of Drug Use Disorders

UNODC organized a training for 19 Albanian policymakers on the Nature, Prevention, and Treatment of Drug Use Disorders from 12-14 April 2022 in Tirana, Albania. Participants from the Ministries of Health and Social Protection, Education, Justice and Interior took active participation during the training which was organized with the generous support from the U.S. State Department Bureau of International Narcotics and Law Enforcement Affairs (INL). This UNODC training was inaugurated by Deputy Minister from the

Advances in Addiction and Recovery

Published by
NAADAC

Advances in Addiction & Recovery, the official publication of NAADAC, is a quarterly digital magazine focused on providing useful, innovative and timely information on trends and best practices in the profession that are beneficial for addiction professionals.  

The winter 2022 issue of the magazine is now available to everyone.